Annual Total Expenses
$49.11 M
+$1.39 M+2.92%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual total expenses is $49.11 million, with the most recent change of +$1.39 million (+2.92%) on December 31, 2023.
- During the last 3 years, CPIX annual total expenses has risen by +$5.28 million (+12.06%).
- CPIX annual total expenses is now at all-time high.
Performance
CPIX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$10.78 M
-$95.20 K-0.88%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly total expenses is $10.78 million, with the most recent change of -$95.20 thousand (-0.88%) on September 30, 2024.
- Over the past year, CPIX quarterly total expenses has dropped by -$4.75 million (-30.59%).
- CPIX quarterly total expenses is now -30.59% below its all-time high of $15.53 million, reached on December 31, 2023.
Performance
CPIX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CPIX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.9% | -30.6% |
| 3 y3 years | +12.1% | +11.9% |
| 5 y5 years | +21.2% | -15.1% |
CPIX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.5% | -30.6% | +4.0% |
| 5 y | 5-year | at high | +12.5% | -30.6% | +11.9% |
| alltime | all time | at high | +394.1% | -30.6% | +316.1% |
Cumberland Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.78 M(-0.9%) |
| Jun 2024 | - | $10.88 M(+4.9%) |
| Mar 2024 | - | $10.37 M(-33.3%) |
| Dec 2023 | $49.11 M(+2.9%) | $15.53 M(+30.0%) |
| Sep 2023 | - | $11.95 M(+10.0%) |
| Jun 2023 | - | $10.87 M(+1.0%) |
| Mar 2023 | - | $10.76 M(-5.7%) |
| Dec 2022 | $47.72 M(+9.3%) | $11.40 M(-2.6%) |
| Sep 2022 | - | $11.70 M(-3.7%) |
| Jun 2022 | - | $12.15 M(-2.6%) |
| Mar 2022 | - | $12.47 M(-1.6%) |
| Dec 2021 | $43.66 M(-0.4%) | $12.67 M(+31.5%) |
| Sep 2021 | - | $9.64 M(-8.2%) |
| Jun 2021 | - | $10.49 M(-3.4%) |
| Mar 2021 | - | $10.86 M(-9.5%) |
| Dec 2020 | $43.82 M(+0.3%) | $12.01 M(+14.8%) |
| Sep 2020 | - | $10.46 M(-6.4%) |
| Jun 2020 | - | $11.18 M(+9.8%) |
| Mar 2020 | - | $10.18 M(-19.9%) |
| Dec 2019 | $43.68 M(+7.8%) | $12.70 M(+25.3%) |
| Sep 2019 | - | $10.13 M(-6.1%) |
| Jun 2019 | - | $10.79 M(+7.3%) |
| Mar 2019 | - | $10.05 M(+23.4%) |
| Dec 2018 | $40.52 M(-10.4%) | $8.15 M(-20.9%) |
| Sep 2018 | - | $10.30 M(-6.6%) |
| Jun 2018 | - | $11.03 M(-0.1%) |
| Mar 2018 | - | $11.04 M(-12.1%) |
| Dec 2017 | $45.23 M(+31.3%) | $12.55 M(+4.3%) |
| Sep 2017 | - | $12.04 M(+16.3%) |
| Jun 2017 | - | $10.35 M(+0.5%) |
| Mar 2017 | - | $10.29 M(+2.5%) |
| Dec 2016 | $34.46 M(+6.3%) | $10.04 M(+15.9%) |
| Sep 2016 | - | $8.66 M(+15.2%) |
| Jun 2016 | - | $7.52 M(-8.7%) |
| Mar 2016 | - | $8.24 M(+4.6%) |
| Dec 2015 | $32.41 M | $7.87 M(+3.4%) |
| Sep 2015 | - | $7.61 M(-7.5%) |
| Jun 2015 | - | $8.24 M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $8.68 M(+3.6%) |
| Dec 2014 | $33.34 M(-6.9%) | $8.38 M(-4.1%) |
| Sep 2014 | - | $8.74 M(+2.4%) |
| Jun 2014 | - | $8.53 M(+11.1%) |
| Mar 2014 | - | $7.69 M(-27.7%) |
| Dec 2013 | $35.83 M(-10.5%) | $10.63 M(+32.2%) |
| Sep 2013 | - | $8.04 M(-2.2%) |
| Jun 2013 | - | $8.22 M(-8.0%) |
| Mar 2013 | - | $8.93 M(-14.5%) |
| Dec 2012 | $40.03 M(-3.1%) | $10.44 M(+9.3%) |
| Sep 2012 | - | $9.55 M(-8.4%) |
| Jun 2012 | - | $10.43 M(+8.5%) |
| Mar 2012 | - | $9.61 M(-15.1%) |
| Dec 2011 | $41.29 M(+4.9%) | $11.32 M(+13.7%) |
| Sep 2011 | - | $9.96 M(-7.5%) |
| Jun 2011 | - | $10.76 M(+16.2%) |
| Mar 2011 | - | $9.26 M(-12.5%) |
| Dec 2010 | $39.37 M(+4.6%) | $10.58 M(+8.5%) |
| Sep 2010 | - | $9.75 M(+0.2%) |
| Jun 2010 | - | $9.73 M(+4.4%) |
| Mar 2010 | - | $9.32 M(-6.0%) |
| Dec 2009 | $37.65 M(+36.0%) | $9.91 M(-11.7%) |
| Sep 2009 | - | $11.23 M(+21.7%) |
| Jun 2009 | - | $9.23 M(+26.6%) |
| Mar 2009 | - | $7.29 M(-12.0%) |
| Dec 2008 | $27.69 M(+29.8%) | $8.28 M(+28.9%) |
| Sep 2008 | - | $6.43 M(-1.4%) |
| Jun 2008 | - | $6.52 M(+0.1%) |
| Mar 2008 | - | $6.51 M(+6.7%) |
| Dec 2007 | $21.34 M(+36.9%) | $6.10 M(+16.5%) |
| Sep 2007 | - | $5.24 M(-1.9%) |
| Jun 2007 | - | $5.34 M(+14.7%) |
| Mar 2007 | - | $4.66 M(-8.7%) |
| Dec 2006 | $15.59 M(+56.9%) | $5.10 M(+25.5%) |
| Sep 2006 | - | $4.06 M(+5.9%) |
| Jun 2006 | - | $3.84 M(+48.1%) |
| Mar 2006 | - | $2.59 M |
| Dec 2005 | $9.94 M | - |
FAQ
- What is Cumberland Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual total expenses year-on-year change?
- What is Cumberland Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly total expenses year-on-year change?
What is Cumberland Pharmaceuticals annual total expenses?
The current annual total expenses of CPIX is $49.11 M
What is the all time high annual total expenses for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual total expenses is $49.11 M
What is Cumberland Pharmaceuticals annual total expenses year-on-year change?
Over the past year, CPIX annual total expenses has changed by +$1.39 M (+2.92%)
What is Cumberland Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of CPIX is $10.78 M
What is the all time high quarterly total expenses for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly total expenses is $15.53 M
What is Cumberland Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, CPIX quarterly total expenses has changed by -$4.75 M (-30.59%)